A study of risk factors of retinopathy of prematurity in a tertiary care hospital

  • Dr. Shivananda I Associate Professor of Pediatrics, Karnataka Institute of Medical Sciences, Hubli, Karnataka. India,
  • Dr. Srinivasa V Associate Professor of Pediatrics, Basaveshwara Medical College, Chitradurga, Karnataka. India.
  • Dr. Kumar G.V. Professor of Pediatrics, Sri Siddhartha Medical College, Tumkur, Karnataka, India,
  • Dr. Vijay Yadav Postgraduate Student in Pediatrics, Basaveshwara Medical College, Chitradurga, Karnataka. India.
Keywords: Retinopathy of prematurity, Newborns, Risk factors

Abstract

Introduction: Retinopathy of prematurity (ROP) is a vaso-proliferative disorder of the retina, which principally occurs in premature neonates during vascular development and maturation stage. ROP is multifactorial disorder.

Objectives: The purpose of this study is to know the risk factors and their correlation with retinopathy of prematurity.

Methods: All neonates born between 28-34 weeks of gestation admitted in NICU, who are under oxygen, were included in the study and screened for ROP. Babies with ocular disorder which interfere with fundus examination and babies who did not complete follow up till complete vascularization of retina were excluded from the study.

Results: A total of 95 neonates were studied for ROP. In babies with gestational age between 30 – 32 weeks, 15.4%, 8.5% in the 32 – 35 weeks and none among those born between more than 35 weeks had ROP. About 12.5% of the patients with no PDA and 57.1% of the patients with PDA had retinopathy of prematurity. About 10.8% of the patients with no anemia and 33.3% with anemia had retinopathy of prematurity. This study had shown that 9.6% of the patients without blood transfusion and 36.4% with blood transfusion had retinopathy of prematurity. In this study 10% of the newborns with no thrombocytopenia and 32% with thrombocytopenia had retinopathy of prematurity.Retinopathy is an important complication of prematurity.

Conclusion: Timely referral of detected ROP cases for treatment prevents blindness. There is need for the obstetricians, neonatologist and ophthalmologist to work in close co-operation to prevent blindness due to ROP.

Downloads

Download data is not yet available.

References

1. Terry TL. Extreme Prematurity and Fibroblastic Overgrowth of Persistent Vascular Sheath Behind Each Crystalline Lens: I. Preliminary report. Am J Ophthalmol. 2018 Aug; 192:xxviii.doi: 10.1016/j.ajo.2018.05.024. DOI:10.1016/j.ajo.2018.05.024.[pubmed]

2. Coats DK, Miller AM, Hussein MA, et al. Involution of retinopathy of prematurity after laser treatment: factors associated with development of retinal detachment. Am J Ophthalmol. 2005 Aug;140(2):214-22. DOI:10.1016/j.ajo.2004.12.106.[pubmed]

3. Lucey JF, Dangman B. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics. 1984 Jan; 73 (1):82-96.[pubmed]

4. Phelps DL. Retinopathy of prematurity: an estimate of vision loss in the United States--1979. Pediatrics. 1981 Jun;67(6):924-5.[pubmed]

5. Gibson DL, Sheps SB, Uh SH, Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics. 1990 Sep;86(3):405-12.[pubmed]

6. Azad R, Chandra P. Retinopathy of prematurity. J Indian Med Assoc. 2005 Jul;103(7):370-2.[pubmed]

7. Lucey JF, Dangman B. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics. 1984 Jan;73(1):82-96.[pubmed]

8. Maheshwari R, Kumar H, Paul VK, Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi. Natl Med J India. 1996 Sep-Oct;9(5):211-4.[pubmed]

9. Paysse EA. Retinopathy of Prematurity. In: Garcia-Prats JA, Saunders RA, Armsby C (Eds.). UpToDate. Available at: http://www.uptodate.com/contents/retinopathy-of-prematurity, updated on: July 27, 2015, last access: July 2015.

10. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. DOI:10.1016/S0140-6736(13)60178-6.[pubmed]

11. Chawla D, Agarwal R, Deorari A, et al. Retinopathy of prematurity. Indian J Pediatr. 2012 Apr;79(4):501-9. doi: 10.1007/s12098-010-0279-7. Epub 2010 Oct 27. [pubmed]

12. Shalev B, Farr AK, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol. 2001 Jul;132(1):76-80.[pubmed]

13. Hakeem AH1, Mohamed GB, Othman MF. Retinopathy of prematurity: a study of prevalence and risk factors. Middle East Afr J Ophthalmol. 2012 Jul-Sep;19(3):289-94. doi: 10.4103/0974-9233.97927. [pubmed]

14. Yang C, Lien R, Yang P, Chu S, Hsu J, Fu R, Chiang M, Analysis of incidence and risk factors of retinopathy of prematurity among very low birth weight infants in north Taiwan, Pediatrics and Neonatology (2011) 52, 321e326.

15. Rekha S, Battu RR. Retinopathy of prematurity: incidence and risk factors. Indian Pediatr. 1996 Dec;33(12):999-1003.[pubmed]

16. Chaudhari S, Patwardhan V, Vaidya U, et al. Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome. Indian Pediatr. 2009 Mar;46(3):219-24. Epub 2009 Jan 1.[pubmed]

17. Shetty SP, Sheety J, Amin H, Shenoy RD, The incidence, risk factors and outcome of retinopathy of prematurity at a tertiary care centre in South India, IOSR – JDMS, 2015:14:6:77- 83.
A study of risk factors of retinopathy of prematurity in a tertiary care hospital
CITATION
DOI: 10.17511/ijpr.2019.i02.11
Published: 2019-02-28
How to Cite
Dr. Shivananda I, Dr. Srinivasa V, Dr. Kumar G.V., & Dr. Vijay Yadav. (2019). A study of risk factors of retinopathy of prematurity in a tertiary care hospital. Pediatric Review: International Journal of Pediatric Research, 6(2), 103-106. https://doi.org/10.17511/ijpr.2019.i02.11
Section
Original Article